← Back
$KLRA All transactions

Kailera Therapeutics, Inc.

C

$ Value

$0

Shares

17,857,143

Price

$0

Filed

Apr 20

Insider

Name

BAIN CAPITAL INVESTORS LLC

Title

CIK

0001040508

Roles

10% Owner

Transaction Details

Transaction Date

2026-04-20

Code

C

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

Each share of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1:1 basis upon the closing of the Issuer's initial public offering. These securities had no expiration date. | Represents securities held directly by BCPE Perseus Investor, LP ("BCPE Perseus"). | Bain Capital Investors, LLC ("BCI") is the manager of Bain Capital XIV General Partner, LLC ("BCPE Fund XIV GP"), which is the general partner of Bain Capital Fund XIV, L.P. ("BCPE Fund XIV"), which is the managing member of BCPE Perseus Investor GP, LLC ("BCPE Perseus GP"), which is the general partner of BCPE Perseus. As a result, each of BCI, BCPE Fund XIV GP, BCPE Fund XIV and BCPE Perseus GP may be deemed to share voting and dispositive power with respect to the securities held by BCPE Perseus. BCI, BCPE Fund XIV GP, BCPE Fund XIV and BCPE Perseus GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Filing Info

Accession No.

0001193125-26-164417

Form Type

4

Issuer CIK

0002096997

BAIN CAPITAL INVESTORS LLC's History

Date Ticker Type Value
2026-04-20 KLRA C
2026-04-20 KLRA C $0
2025-05-16 WAY J

Other Insiders at KLRA (90d)

Insider Bought Sold Last
Kaplan Andrew T. / BAIN CAPITAL INVESTORS LLC $134.4M 2026-04-20
Bain Capital Life Sciences Investors, LLC / Koppel Adam $25.0M 2026-04-20
RTW INVESTMENTS, LP $8.0M 2026-04-20
BAIN CAPITAL INVESTORS LLC 2026-04-20
MILLIGAN JOHN F 2026-04-16
Renaud Ronald C JR
CEO & President
2026-04-16
MACKAY MARTIN 2026-04-16
Koppel Adam 2026-04-20
Pagan Douglas W.
Chief Financial Officer
2026-04-16
Bain Capital Life Sciences Investors, LLC 2026-04-20
Burgess Paul D.
See Remarks
2026-04-16
Cloghessy Paula
Chief People Officer
2026-04-16
Kaplan Andrew T. 2026-04-20
Clyburn Frank 2026-04-16
Hite Christopher 2026-04-16
Akamine Scott
Chief Legal Officer
2026-04-16
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2026-04-20
Coleman Jamie Beth
Chief Commercial Officer
2026-04-16
Wasserman Scott M.
Chief Medical Officer
2026-04-16